Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,239 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Efficacy and Tolerability of Irbesartan/Amlodipine Combination Therapy in Patients With Essential Hypertension Whose Blood Pressure Were not Controlled by Irbesartan Monotherapy.
Lee HY, Min KW, Han KA, Kim JS, Ahn JC, Kim MH, Lee JB, Shin SH, Kim CJ, Kim KH, Cho DK, Choi J, Rhee MY, Her SH, Kim W, Na JO, Cho GY, Kim SY, Park GM, Lee BK, Jo SH, Lee BW, Sohn IS, Kim DI, Ihm SH, Lee SH, Chung JW, Cho EJ, Son JW, Oh SJ, Hwang JY, Jeong JO, Han KR, Yoon HJ, Seo SM, Chung WJ, Bae JW, Choi JH, Hyun BJ, Cha JE, Yoo SJ, Shin J. Lee HY, et al. Among authors: kim w, kim di, kim sy, kim cj, kim js, kim mh, kim kh. Clin Ther. 2024 May 3:S0149-2918(24)00084-5. doi: 10.1016/j.clinthera.2024.04.004. Online ahead of print. Clin Ther. 2024. PMID: 38704294 Free article.
A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Fimasartan/Amlodipine Combined Therapy Versus Fimasartan Monotherapy in Patients With Essential Hypertension Unresponsive to Fimasartan Monotherapy.
Kim KI, Shin MS, Ihm SH, Youn HJ, Sung KC, Chae SC, Nam CW, Seo HS, Park SM, Rhee MY, Kim MH, Cha KS, Kim YJ, Kim JJ, Chun KJ, Yoo BS, Park S, Shin ES, Kim DS, Il Kim D, Kim KH, Joo SJ, Jeong JO, Shin J, Kim CH. Kim KI, et al. Among authors: kim ds, kim jj, kim yj, kim ch, kim mh, kim kh. Clin Ther. 2016 Oct;38(10):2159-2170. doi: 10.1016/j.clinthera.2016.07.008. Epub 2016 Aug 5. Clin Ther. 2016. PMID: 27502326 Clinical Trial.
A Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and the Tolerability of a Triple Combination of Amlodipine/Losartan/Rosuvastatin in Patients With Comorbid Essential Hypertension and Hyperlipidemia.
Lee HY, Kim SY, Choi KJ, Yoo BS, Cha DH, Jung HO, Ryu DR, Choi JH, Lee KJ, Park TH, Oh JH, Kim SM, Choi JY, Kim KH, Shim J, Kim WS, Choi SW, Park DG, Song PS, Hong TJ, Rhee MY, Rha SW, Park SW. Lee HY, et al. Among authors: kim sy, kim sm, kim ws, kim kh. Clin Ther. 2017 Dec;39(12):2366-2379. doi: 10.1016/j.clinthera.2017.10.013. Epub 2017 Nov 14. Clin Ther. 2017. PMID: 29150250 Free article. Clinical Trial.
Efficacy and safety of low-dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double-blind, parallel, phase II trial.
Sung KC, Sung JH, Cho EJ, Ahn JC, Han SH, Kim W, Kim KH, Sohn IS, Shin J, Kim SY, Kim KI, Kang SM, Park SJ, Kim YJ, Shin JH, Park SM, Park CG. Sung KC, et al. Among authors: kim yj, kim w, kim sy, kim kh, kim ki. J Clin Hypertens (Greenwich). 2022 Oct;24(10):1298-1309. doi: 10.1111/jch.14570. Epub 2022 Sep 12. J Clin Hypertens (Greenwich). 2022. PMID: 36094783 Free PMC article. Clinical Trial.
Prevalence and clinical features of bone morphogenetic protein receptor type 2 mutation in Korean idiopathic pulmonary arterial hypertension patients: The PILGRIM explorative cohort.
Jang AY, Kim BG, Kwon S, Seo J, Kim HK, Chang HJ, Chang SA, Cho GY, Rhee SJ, Jung HO, Kim KH, Seo HS, Kim KH, Shin J, Lee JS, Kim M, Lee YJ, Chung WJ. Jang AY, et al. Among authors: kim hk, kim bg, kim m, kim kh. PLoS One. 2020 Sep 23;15(9):e0238698. doi: 10.1371/journal.pone.0238698. eCollection 2020. PLoS One. 2020. PMID: 32966279 Free PMC article.
PRE-OPerative ECHOcardiograhy for prevention of cardiovascular events after non-cardiac surgery in intermediate- and high-risk patients: protocol for a low-interventional, mixed-cohort prospective study design (PREOP-ECHO).
Kim EK, Choi HM, Choi EY, Lee HS, Park G, Han DW, Lee SE, Park CS, Hwang JW, Choi JH, Kim MN, Kim HK, Kim DH, Shin SH, Sohn IS, Shin MS, Na JO, Cho I, Lee SH, Park YH, Park TH, Kim KH, Cho GY, Jung HO, Park DG, Hong JY, Kang DH. Kim EK, et al. Among authors: kim mn, kim hk, kim dh, kim kh. Trials. 2022 Sep 14;23(1):776. doi: 10.1186/s13063-022-06701-2. Trials. 2022. PMID: 36104714 Free PMC article.
Characteristics According to Frailty Status Among Older Korean Patients With Hypertension.
Choi JY, Lee HY, Lee JH, Hong Y, Park SK, Ryu DR, Lee JH, Hwang S, Kim KH, Lee SH, Kim SY, Park JH, Kim SH, Kim HL, Choi JH, Kim CH, Cho MC, Kim KI. Choi JY, et al. Among authors: kim hl, kim sh, kim ch, kim sy, kim kh, kim ki. J Korean Med Sci. 2024 Mar 18;39(10):e84. doi: 10.3346/jkms.2024.39.e84. J Korean Med Sci. 2024. PMID: 38501181 Free PMC article. Clinical Trial.
Optimal blood pressure target in the elderly: rationale and design of the HOW to Optimize eLDerly systolic Blood Pressure (HOWOLD-BP) trial.
Lee DH, Lee JH, Kim SY, Lee HY, Choi JY, Hong Y, Park SK, Ryu DR, Yang DH, Hwang SJ, Choi JH, Kim KH, Lee SH, Joo SJ, Park JH, Kim SH, Kim HL, Kim KI, Cho MC. Lee DH, et al. Among authors: kim hl, kim sh, kim sy, kim kh, kim ki. Korean J Intern Med. 2022 Sep;37(5):1070-1081. doi: 10.3904/kjim.2022.067. Epub 2022 Jul 21. Korean J Intern Med. 2022. PMID: 35859277 Free PMC article. Clinical Trial.
10,239 results
You have reached the last available page of results. Please see the User Guide for more information.